ALPS Advisors’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $362K | Buy |
|
|||||
|
2025
Q1 | $400K | Sell |
|
|||||
|
2024
Q4 | $357K | Sell |
|
|||||
|
2024
Q3 | $348K | Sell |
|
|||||
|
2024
Q2 | $333K | Sell |
|
|||||
|
2024
Q1 | $1.67M | Buy |
|
|||||
|
2023
Q4 | $1.22M | Sell |
|
|||||
|
2023
Q3 | $920K | Sell |
|
|||||
|
2023
Q2 | $1.34M | Buy |
|
|||||
|
2023
Q1 | $1.49M | Sell |
|
|||||
|
2022
Q4 | $1.69M | Buy |
|
|||||
|
2022
Q3 | $986K | Sell |
|
|||||
|
2022
Q2 | $748K | Sell |
|
|||||
|
2022
Q1 | $1.26M | Sell |
|
|||||
|
2021
Q4 | $1.32M | Sell |
|
|||||
|
2021
Q3 | $1.06M | Sell |
|
|||||
|
2021
Q2 | $1.25M | Sell |
|
|||||
|
2021
Q1 | $1.24M | Buy |
|
|||||
|
2020
Q4 | $885K | Buy |
|
|||||
|
2020
Q3 | $631K | Buy |
|
|||||
|
2020
Q2 | $652K | Sell |
|
|||||
|
2020
Q1 | $721K | Sell |
|
|||||
|
2019
Q4 | $784K | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $1.27M | Buy |
|
|||||
|
2018
Q4 | $456K | Buy |
|
|||||
|
2018
Q3 | $686K | Buy |
|
|||||
|
2018
Q2 | $465K | Buy |
|
|||||
|
2018
Q1 | $328K | Buy |
|
|||||
|
2017
Q4 | $435K | Buy |
|